3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
129
Precursor Cell Lymphoblastic Leukemia-Lymphoma
81
Hematologic Neoplasms
66
Leukemia, Lymphocytic, Chronic, B-Cell
65
Leukemia
53
Myelodysplastic Syndromes
49
Lymphoma
34
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
30
Lymphoma, Non-Hodgkin
29
Multiple Myeloma
21
Burkitt Lymphoma
21
Leukemia, Myelomonocytic, Chronic
20
Recurrence
18
Neoplasms
18
Lymphoma, Large B-Cell, Diffuse
15
Leukemia, B-Cell
14
Hodgkin Disease
14
Myeloproliferative Disorders
13
Lymphoma, Mantle-Cell
12
Leukemia, Biphenotypic, Acute
12
Lymphoma, Follicular
11
Lymphoma, B-Cell
11
Waldenstrom Macroglobulinemia
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, B-Cell, Marginal Zone
10
Anemia, Refractory, with Excess of Blasts
10
Blast Crisis
8
Primary Myelofibrosis
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Myelodysplastic-Myeloproliferative Diseases
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Other hematologic neoplasm
×
30 days
×
Clear all
NCT01212926
2026-05-28
CA2D
University Hospital, Bordeaux
Phase NA
Completed
100 enrolled